Skip to main content
VENTURE LIFE GROUP PLC logo

VENTURE LIFE GROUP PLC — Investor Relations & Filings

Ticker · VLG ISIN · GB00BFPM8908 LEI · 213800S8CZUPLAB2KC70 IL Manufacturing
Open in API
Filings indexed 436 across all filing types
Latest filing 2021-09-23 Interim / Quarterly Rep…
Country GB United Kingdom
Listing IL VLG

About VENTURE LIFE GROUP PLC

https://www.venture-life.com/

Venture Life Group PLC is a consumer self-care company that develops, manufactures, and distributes products for the global market. The company focuses on non-prescription items that consumers can purchase directly, addressing preventative wellness and quality of life issues, particularly those related to an aging population. Its product portfolio encompasses a range of categories, including medical devices, food supplements, dermo-cosmetics, and oral healthcare. Venture Life manages the entire product lifecycle, from initial concept and in-house manufacturing to international commercialization through a network of global partners.

Recent filings

Filing Released Lang Actions
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is an 'Unaudited interim results' report for Venture Life Group PLC for the six months ended 30 June 2021. It contains detailed financial highlights, commercial highlights, a CEO statement, and a management discussion of financial performance (gross margins, revenue, EBITDA, etc.). As it provides comprehensive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2021
2021-09-23 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing the 'acquisition or disposal of voting rights' and the resulting percentage of ownership (5.005899%). This form is used to report changes in significant share ownership thresholds. This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general regulatory filing fallback.
2021-09-07 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document is very short (1938 characters) and its primary content is an announcement regarding a 'Second Price Monitoring Extension' for a security, referencing the 'RNS Number' and stating that the information is provided by 'RNS, the news service of the London Stock Exchange.' This structure—a brief notification about a market event or status update distributed via the RNS system—fits best under the general Regulatory Filings category, as it is not a specific financial report (like 10-K, IR, ER) or a corporate action announcement (like DIV, SHA, MANG). Since it is a direct regulatory notification distributed through the official channel (RNS), and it doesn't fit the more specific definitions, RNS is the most appropriate classification.
2021-08-13 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1921 characters) and contains the header 'RNS Number : 5869I'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief, time-sensitive announcement disseminated via the RNS system—fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-08-13 English
Trading Update and Progress on recent Acquisitions
Earnings Release Classification · 98% confidence The document is identified by the 'RNS Number' header and contains a 'Trading Update and Progress on recent Acquisitions' for Venture Life Group PLC, reporting revenues for the six months ended 30th June 2021 (£13.8 million). This structure—a brief update on recent performance, M&A integration progress, and outlook, often released via an official news service like RNS—is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it provides key financial highlights (£13.8m revenue, comparison to H1 2020) but is not the comprehensive 'Interim Report' (IR) itself, and it is clearly disseminated through the London Stock Exchange's RNS system, it fits best as an Earnings Release (ER). The presence of the RNS footer confirms its nature as a regulatory news service filing. H1 2021
2021-08-13 English
Acquisition of Oncology Support Product Assets
Regulatory Filings Classification · 98% confidence The document is a formal announcement released via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the 'RNS Number' and the concluding boilerplate text referencing RNS and the FCA. The content details a specific corporate action: the 'Acquisition of Brands and Assets from Helsinn Healthcare SA' for a specific consideration. This type of announcement, detailing a significant transaction (M&A activity), is typically classified under a specific corporate action code. Since it is a definitive announcement of a takeover/acquisition, the most appropriate code is TAR (M&A Activity). It is not a general regulatory filing (RNS) because it fits a more specific category, nor is it an Earnings Release (ER) or Interim Report (IR).
2021-08-06 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.